Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
61 /100
HIGH RISK
Score updated Aug 28, 2026

AIFF — Firefly Neuroscience, Inc. Dilution Risk Tracker

Track AIFF dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AIFF — Get alerts when the score changes →

As of August 28, 2026, Firefly Neuroscience, Inc. (AIFF) has a DilutionWatch DilutionScore of 61/100, rated HIGH dilution risk. Firefly Neuroscience, Inc. has a market capitalization of $27.56M, 15.69M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $7.43M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
40
📊 Float Risk
15
⚠️ Warrant Exposure
40
🔄 Convertible Debt
35

Dilution Forecast

Watch
Minor dilution signals detected
model est. 23%
🔄 Reverse Split model est. 30%
• 50-day avg $1.91 approaching $1 threshold
💰 Capital Raise model 18%
• Active ATM program with $7M remaining capacity
🔁 Convertible Conversion model 15%
• Convertible debt present: 9.2% potential dilution
🔔 Track AIFF — Get forecast alerts →

Market Data

Market Cap$27.56M
Shares Outstanding15.69M
Float13.58M
Cash$9.23M
Debt$450.0K
Short InterestN/A

Institutional Holdings

10 institutional holders · 1.09M shares
#1 Jane Street Group, LLC 180.2K shares
#2 Schonfeld Strategic Advisors Llc 177.2K shares
#3 Blackrock Inc. 169.4K shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest598.5K
Days to Cover5.6
% of Float4.4%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30
xbrl XBRL CONVERTIBLE 2026-06-30
8-K 8K EVENT 2026-04-22
4 INSIDER TRANSACTION 2026-03-12
4 INSIDER TRANSACTION 2026-03-12
Full SEC filing analysis available with free account

Recent News

No recent news

Factual AIFF Dilution Snapshot

Firefly Neuroscience, Inc. (AIFF) has a DilutionScore of 61/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track AIFF Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AIFF — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for AIFF
AIFF FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.